Talk:Cannabinoid receptor modulator

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC
	This article was accepted from this draft on 5 August 2026 by reviewer WeirdNAnnoyed (talk · contribs).

Pharmacology

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
???	This article has not yet received a rating on the project's importance scale.

Some concerns about the draft

Latest comment: 9 days ago1 comment1 person in discussion

I am studying to be an AfC reviewer and looked over your draft. I wanted to mention some concerns which you should address while waiting for review.

(1) A lot of points are cited to primary research papers which mention them in passing. It would be better, when possible, to use secondary sources such as review papers (your source "Cannabinoid receptor 1 ligands" is a great example but only for receptor 1) and only use primary papers when their research directly involves your claim. I am left feeling that these sources may have been found by LLM, which can be acceptable but do not trust the LLM's summary of the source, they are not reliable for that purpose.

(2) Everything I have read about Epidiolex says that it is purified from plants, but the article refers to it as synthetic--what is the source for this? And referring to CBD in general as synthetic is definitely wrong.

(3) The second paragraph under Theraputic Uses is confusing as it doesn't separate CB1R agonists from antagonists.

(4) Under Mechanism of action for CBD there is confusion throughout this paragraph between cannabidiol and cannabinoid. (I'd use "CBD" a lot more to help avoid this.) This may happen elsewhere as well.

(5) The detail on individual drugs may be excessive, given that individual articles already exist.

(6) A little history would be a nice long-term addition to the article, though definitely not needed to get through review!

If you have any questions feel free to put a message on my Talk page. M kuhner (talk) 23:10, 31 July 2026 (UTC)Reply